
Novartis AG NVS
$ 158.93
1.18%
Annual report 2024
added 01-24-2026
Novartis AG DIO Ratio 2011-2026 | NVS
Annual DIO Ratio Novartis AG
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 130 | 131 | 128 | 135 | 131 | 114 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 135 | 114 | 128 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 0.84 | 2.78 % | $ 4.58 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Amarin Corporation plc
AMRN
|
292 | $ 15.08 | 2.24 % | $ 6.15 B | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Arena Pharmaceuticals
ARNA
|
160 | - | -6.81 % | $ 3.04 B | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Baudax Bio
BXRX
|
596 | - | 0.59 % | $ 63 K | ||
|
Amneal Pharmaceuticals
AMRX
|
123 | $ 14.79 | 1.83 % | $ 4.57 B |